CAPTIVATE: 1-year DFS results from the MRD cohort in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:17 4 years ago 106 Далее Скачать
Ibrutinib plus Venetoclax for first-line treatment of chronic lymphocytic leukaemia ecancer 6:55 3 years ago 377 Далее Скачать
CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax for CLL/SLL ecancer 11:23 3 years ago 92 Далее Скачать
CAPTIVATE: First-line ibrutinib plus venetoclax for CLL/SLL ecancer 10:41 3 years ago 298 Далее Скачать
The first presentation of disease-free survival results from the CAPTIVATE study OncologyTube 2:21 4 years ago 17 Далее Скачать
Frontline ibrutinib + venetoclax in CLL: Results from a fixed duration cohort of the CAPTIVATE study Lymphoma Hub 4:45 3 years ago 108 Далее Скачать
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 3 years ago 175 Далее Скачать
2 year DFS data from the CAPTIVATE trial VJHemOnc – Video Journal of Hematology & HemOnc 3:37 2 years ago 65 Далее Скачать
Support Shown for Fixed-Duration Combination Ibrutinib + Venetoclax for CLL Patients CheckRare 4:46 4 years ago 94 Далее Скачать
CAPTIVATE trial: 5.5yr follow-up of the fixed-duration cohort VJHemOnc – Video Journal of Hematology & HemOnc 1:34 5 months ago 96 Далее Скачать
Update on fixed-duration cohort of CAPTIVATE trial for CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 2:27 3 years ago 216 Далее Скачать
Five-year follow-up of the CAPTIVATE trial: ibrutinib retreatment in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:00 10 months ago 228 Далее Скачать
Updates from CAPTIVATE: ibrutinib and venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 5:54 4 years ago 494 Далее Скачать
ASH 2020: Dr. Wierda Discusses Phase 2 CAPTIVATE Study Data DocWire 7:39 4 years ago 185 Далее Скачать
CAPTIVATE and beyond: combination therapies for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:40 6 years ago 66 Далее Скачать
Updates in CLL - 2023 Best of Hematology Conference Total Health | Oncology 51:26 1 year ago 5 189 Далее Скачать
Outcomes in high-risk CLL patients following fixed-duration treatment with ibrutinib plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 2:43 1 year ago 621 Далее Скачать
Positive results for CAPTIVATE: ibrutinib and venetoclax for CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:14 6 years ago 108 Далее Скачать
